The International Liner Shipping Working Group will hold Chair elections on March 13, 15.30 China time. At that meeting, Position Paper issues as well as up-to-date relevant developments concerning the group will be discussed.

The Chairperson and Vice Chair play a crucial role in driving the Working Group, including a leading role in the drafting of the annual Position Paper, in communicating key messages to Chinese and European government authorities, and in steering activities of the Working Group. The ideal Chair and Vice Chair is a senior industry representative with relevant expertise and government contacts who has the time and willingness to support the Working Group for 12 months. Previous participation in the Working Group is essential. Before applying for the position of Chair or Vice Chair, we recommend that you obtain approval from your company.

The maximum duration of the Chairperson and Vice Chairperson position is three consecutive years. Only candidates who are physically based in China are eligible to run for Chair or Vice Chair positions.

The International Liner Shipping Working Group is going to elect one Chair and one Vice Chair (in Shanghai).

• 2020-03-13 | 15:30 - 17:00
• Zoom meeting (online or via call in)

We would like to invite you to attend the Legal & Competition Working Group election meeting on Global Talents Management during 2019-nCoV Epidemic on 13th March, 9:30 – 12:00 via the digital platform Zoom (you will receive a link upon registration). This meeting will consist of three parts.

• 2020-03-13 | 09:30 - 12:00
• Zoom Online Meeting Platform

We would like to invite you to attend the Legal & Competition Working Group election meeting on Global Talents Management during 2019-nCoV Epidemic on 13th March, 9:30 – 12:00 via the digital platform Zoom (you will receive a link upon registration). This meeting will consist of three parts.

• 2020-03-13 | 09:30 - 12:00
• Zoom Online Meeting Platform

自中美贸易争端以来，中国财政部已经开展了两批对美加征关税的排除申请工作，这两批排除申请主要是审核申请主体在商品替代 来源方面面临的困难、加征关税对申请主体造成经济损害程度，以及对相关行业造成负面结构性影响等。2020年2月18日，财政部宣布，自3月2日起对按市场化和商业化原则自美采购的进口商品开展新的加征关税排除工作。

On 18 Feb 2020, the Chinese Ministry of Finance (MOF) announced a new application process of Market-oriented Procurement Exclusion (MPE) for Chinese retaliatory duty levied on US-origin products. Since 2 Mar, MOF has started to review MPE applications raised by companies and some applications have been approved.

为使会员企业把握这一契机，积极评估和参与此次排除申请，争取最大限度享受政策红利，欧盟商会诚邀您参与我们这次webinar。

In order to help our members make the best use of the MPE policy and mitigate the negative impact of China-US trade conflict, we are pleased to invite you to join our webinar on 12 March.

• 2020-03-12 | 16:00 - 17:30
• Online - Zoom

In the past few weeks, enormous efforts are made by the government and businesses in China to battle the coronavirus epidemic. Amid this critical period, emerging technologies, such as cloud computing, 5G, and AI, have stood out to enable a new norm of working mobility and connectivity. The crisis, nevertheless, has made digital strategy a new necessity for many enterprises, thereby catalyzing China’s transition into the modern digital economy

• 2020-03-12 | 15:30 - 17:00
• online

We would like to invite you to attend the IPR Working Group election meeting on Patent Dispute on Novel Coronavirus Drug Remdeseviron 12th March, 14:00 – 16:00 via the digital platform Zoom (you will receive a link upon registration). This meeting will consist of three parts.

Firstly, this WG meeting will include the IPR Working Group 2020-2021 Chair elections. Only IPR WG members who had their registration confirmed for this meeting will have the right to vote online, with one vote per company. Online voting instructions will be sent via email to individual attendees prior to the meeting.

The second part of the WG meeting would be to discuss the Patent Issues with Novel Coronavirus Drug Remdesevir. At this meeting, Ms. Guo Songxi, Patent Counsel at Bayer China, will discuss the risks to IP Protection as it relates to the development of a drug to cure illness brought about by the novel coronavirus.

The third part of the Working Group meeting would be to brainstorm for the key recommendations for the 2020/2021 IPR position paper that will be drafted this coming half year (for the 2019/2020 IPR position paper click here).

• 2020-03-12 | 14:00 - 16:00
• ZOOM Online Meeting

We would like to invite you to attend the IPR Working Group election meeting on Patent Dispute on Novel Coronavirus Drug Remdeseviron 12th March, 14:00 – 16:00 via the digital platform Zoom (you will receive a link upon registration). This meeting will consist of three parts.

Firstly, this WG meeting will include the IPR Working Group 2020-2021 Chair elections. Only IPR WG members who had their registration confirmed for this meeting will have the right to vote online, with one vote per company. Online voting instructions will be sent via email to individual attendees prior to the meeting.

The second part of the WG meeting would be to discuss the Patent Issues with Novel Coronavirus Drug Remdesevir. At this meeting, Ms. Guo Songxi, Patent Counsel at Bayer China, will discuss the risks to IP Protection as it relates to the development of a drug to cure illness brought about by the novel coronavirus.

The third part of the Working Group meeting would be to brainstorm for the key recommendations for the 2020/2021 IPR position paper that will be drafted this coming half year (for the 2019/2020 IPR position paper click here).

• 2020-03-12 | 14:00 - 16:00
• ZOOM Online Meeting

We are pleased to invite the experts from State Power Grid to speak about the perspective and outlook in Dilemma

• 2020-03-11 | 14:00 - 15:30
• ZOOM on line meeting

The European Union Chamber of Commerce in China, together with Ernst & Young (China) Advisory Limited, is thrilled to invite you to participate in the Webinar on March 11th to assist you to properly understand Human Resource Incentive Policies during the Virus Outbreaks. This event is in Chinese.中国欧盟商会与安永（中国）企业咨询有限公司荣幸地邀请您参加3月11日线上“疫情期间人力资源激励政策”相关文件及政策解读。本活动语言为中文。

• 2020-03-11 | 14:00 - 15:15
• online

Rules of Airworthiness Approval of Civil Aviation Products and Components （CCAR-21-R4）is the essential legal document to regulate the aeronautic manufacture concerning the airworthiness approval for the design, manufacturer of the aircraft and components.

• 2020-03-10 | 14:00 - 15:30
• ZOOM on line meeting